12 Health Care Stocks Moving In Friday's Pre-Market Session
VivoSim Labs Inc VIVS
$0.34
▼ -10.73%
($-0.04)
🎈 Low Float
🗓️ Earnings Next Week
Open
$0.42
Prev Close
$0.39
Day Range
$0.32 – $0.42
52W Range
$0.31 – $5.30
Market Cap
$1.20M
Beta
1.51
EPS (TTM)
$-5.33
📋 Company Profile
| Industry | Biotechnology |
| Country | US |
| Exchange | NASDAQ NMS - GLOBAL MARKET |
| Currency | USD |
| IPO Date | 2013-08-02 |
| Shares Out. | 12,060,000 |
| Website | organovo.com/ ↗ |
| Phone | 18009279800 |
| Employees | 15 |
| Revenue | $40,000 |
| Gross Profit | $40,000 |
| Net Income | -$5.8M |
| Total Assets | $7.4M |
| Total Liabilities | $8.5M |
| Equity | -$1.1M |
About VivoSim Labs Inc
VivoSim Labs Inc is a pharmaceutical and biotechnology services company focused on testing drugs and drug candidates in three-dimensional human tissue models of the liver and intestine. The Company provides liver and intestinal toxicology insights using its new approach methodologies and models and offers liver toxicology predictive screening and research services, as well as services to predict and study the intestinal side effect profiles of therapeutic candidates at all stages of drug development. Its 3D human tissue platform includes expertise in 3D organoids, such as spheroids, and proprietary cell culture techniques.
VivoSim Labs Inc is a publicly traded company under the ticker symbol VIVS on the NASDAQ NMS - GLOBAL MARKET, operating in the Biotechnology industry. Quotes and metrics shown here are sourced from public market data and refreshed regularly.
📊 Analyst Ratings
7 analysts (2021-12-01)